EUCTR2004-000687-27-SK进行中（未招募）1 期
A 52-week, open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2000 mg/d in the treatment of manic episodes of bipolar I disorder - D2303E1
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 215
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. written informed consent provided prior to participation in the extension study
- •2. successful completion of study CLIC477D2303
- •3. cooperation and willingness to comply with all study requirements
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. premature discontinuation from study CLIC477D2303
- •2. failure to comply with study CLIC477D2303
研究者
相似试验
已完成
不适用
Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I DisorderPER-105-06OVARTIS BIOSCIENSES PERU S.A.,
进行中（未招募）
不适用
A 52-week open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2000 mg/d in the treatment of manic episodes of bipolar I disorderBipolar I disorder, manic and mixed episodesEUCTR2004-000686-35-FIovartis Pharma AG215
进行中（未招募）
1 期
An extension study to evaluate the long term safety, tolerability and effectiveness of SEP-4199 CR in patients with major depressive episodes associated with Bipolar I disorder.Major Depressive Episodes Associated with Bipolar I DisorderMedDRA version: 20.0Level: PTClassification code 10004939Term: Bipolar I disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-002108-11-HRSunovion Pharmaceuticals Inc.355
进行中（未招募）
1 期
An extension study to evaluate the long term safety, tolerability and effectiveness of SEP-4199 CR in patients with major depressive episodes associated with Bipolar I disorder.Major Depressive Episodes Associated with Bipolar I DisorderMedDRA version: 20.0Level: PTClassification code 10004939Term: Bipolar I disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-002108-11-SKSunovion Pharmaceuticals Inc.355
进行中（未招募）
3 期
A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).JPRN-jRCT2031220302Yabuuchi Kazuki355